(Q53463442)

14 May 2018

title

The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome). (English)

1 reference

14 May 2018

main subject

mucopolysaccharidosis II

1 reference

1 reference

A R Garcia

1

1 reference

14 May 2018

J Pan

series ordinal

2

1 reference

14 May 2018

J C Lamsa

series ordinal

3

1 reference

14 May 2018

J Muenzer

series ordinal

4

1 reference

14 May 2018

publication date

16 September 2007

1 reference

14 May 2018

Journal of Inherited Metabolic Disease

published in

1 reference

14 May 2018

volume

30

1 reference

14 May 2018

issue

6

1 reference

14 May 2018

page(s)

924-934

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1007/s10545-007-0641-8

exact match

0 references

cites work

Enzyme replacement therapy in feline mucopolysaccharidosis I.

1 reference

12 December 2020

A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease).

1 reference

12 December 2020

Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery

1 reference

12 December 2020

Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses.

1 reference

12 December 2020

Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency

1 reference

12 December 2020

Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI

1 reference

12 December 2020

Reduction of GAG storage in MPS II mouse model following implantation of encapsulated recombinant myoblasts

1 reference

12 December 2020

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

1 reference

12 December 2020

Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene

1 reference

12 December 2020

Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue.

1 reference

12 December 2020

Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

12 December 2020

A canine model of human alpha-L-iduronidase deficiency

1 reference

12 December 2020

Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report

1 reference

12 December 2020

Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase

1 reference

12 December 2020

Preclinical dose ranging studies for enzyme replacement therapy with idursulfase in a knock-out mouse model of MPS II

1 reference

12 December 2020

10.1007/S10545-007-0641-8

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

17876721

1 reference

14 May 2018